Related Experiment Video
Updated: Sep 17, 2025

Determining the Likelihood of Variant Pathogenicity Using Amino Acid-level Signal-to-Noise Analysis of Genetic Variation
Published on: January 16, 2019
Novel Pathogenic Variant Confirms the Association of REST and Jones Syndrome
Valentina Lodato1, Massimo Galli2, Giacomo D'Angeli2
1Department of Experimental Medicine, Division of Medical Genetics, San Camillo-Forlanini Hospital, Rome, Italy.
Abstract:
Jones syndrome (JS) is an ultra-rare autosomal dominant condition characterized by gingival fibromatosis and progressive sensorineural hearing loss. It has been recently demonstrated in members of a Finnish family to co-segregate with heterozygosity for a frameshift variant in the fifth and last exon of the repressor element 1-silencing transcription factor gene (REST). Here, we report the first Italian family in which JS was diagnosed in the proband, a 38-year-old woman, and in her mother. Exome Sequencing identified in both, but not in clinically unaffected members of the family (i.e., a sister and the brother of the proband), the heterozygous pathogenic variant c.2645T>G (p.Leu882*) in exon-5 of the REST gene. This study confirms that exon-5 REST variants cause JS.
More Related Videos
Related Concept Videos
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
Rous Sarcoma Virus (RSV) and Cancer
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Single Nucleotide Polymorphisms-SNPs
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The...

